 |
Articles: Rheumatoid Arthritis |
Prior Articles
Effective anti-tnf-î± therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis
Journal of Rheumatology, 10/09/09
The role of biomarkers in the management of patients with rheumatoid arthritis
Current Rheumatology Reports, 10/09/09 Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09 Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Cochrane Reviews, 10/09/09
Revew Article
The role of Toll-like receptors in rheumatoid arthritis
Current Rheumatology Reports, 10/09/09 Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics
Modern Rheumatology, 10/08/09 Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients
Rheumatology, 10/08/09 The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: A systematic comparison of 3- and 6-month response rates in trials of biologic agents.
Annals of Rheumatic Diseases, 10/08/09
Exclusive Author Commentary Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients
Journal of Clinical Rheumatology (JCR), 10/08/09 Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/08/09 Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis
Cochrane Reviews, 10/08/09 Employer Model of Workplace Impacts of Anti-TNF Therapy for Rheumatoid Arthritis
Journal of Occupational and Environmental Medicine, 10/08/09 Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis
Arthritis Research & Therapy, 10/07/09
Free full text
Intranasal administration of recombinant Human Cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: A Phase II, multicenter, double-blind, randomized, placebo-controlled, parallel group dose-finding trial [Extended Report]
Annals of Rheumatic Diseases, 10/07/09 TNF{alpha} blockade impairs dendritic cell survival and function in rheumatoid arthritis [Extended Report]
Annals of Rheumatic Diseases, 10/07/09 Health-economic assessment of combination therapy for rheumatoid arthritis with methotrexat and etanercept based on the TEMPO Study
Zeitschrift für Rheumatologie, 10/07/09 Pulmonary Nodulosis and Aseptic Granulomatous Lung Disease Occurring in Patients with Rheumatoid Arthritis Receiving Tumor Necrosis Factor-alpha-Blocking Agent: A Case Series
Journal of Rheumatology, 10/06/09 Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables
Modern Rheumatology, 10/05/09 Monocyte derived interleukin (IL)-23 is an important determinant of synovial Il-17A expression in rheumatoid arthritis
Journal of Rheumatology, 10/05/09 Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs
Journal of Rheumatology, 10/05/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology
more...
|
250 Available Pages
|
|
